Marshall Wace’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-945,840
| Closed | -$24.9M | – | 2693 |
|
|
2024
Q2 | $24.9M | Sell |
945,840
-510,060
| -35% | -$13.5M | 0.03% | 393 |
|
|
2024
Q1 | $44.2M | Buy |
1,455,900
+15,857
| +1% | +$482K | 0.07% | 251 |
|
|
2023
Q4 | $40.5M | Buy |
1,440,043
+1,275,233
| +774% | +$35.8M | 0.07% | 251 |
|
|
2023
Q3 | $4.47M | Sell |
164,810
-1,641,811
| -91% | -$44.6M | 0.01% | 812 |
|
|
2023
Q2 | $55.5M | Buy |
1,806,621
+1,134,091
| +169% | +$34.9M | 0.11% | 176 |
|
|
2023
Q1 | $24.2M | Buy |
+672,530
| New | +$24.2M | 0.05% | 348 |
|
|
2022
Q4 | – | Sell |
-432,250
| Closed | -$17.4M | – | 2761 |
|
|
2022
Q3 | $17.4M | Buy |
+432,250
| New | +$17.4M | 0.04% | 471 |
|
|
2022
Q2 | – | Sell |
-74,655
| Closed | -$2.91M | – | 3098 |
|
|
2022
Q1 | $2.91M | Sell |
74,655
-116,191
| -61% | -$4.53M | 0.01% | 1482 |
|
|
2021
Q4 | $7.61M | Sell |
190,846
-1,011,134
| -84% | -$40.3M | 0.01% | 981 |
|
|
2021
Q3 | $43.4M | Buy |
+1,201,980
| New | +$43.4M | 0.18% | 81 |
|
|
2020
Q4 | – | Sell |
-29,255
| Closed | -$1.23M | – | 1997 |
|
|
2020
Q3 | $1.23M | Buy |
+29,255
| New | +$1.23M | 0.01% | 912 |
|